Page 271 - Read Online

Burns et al. Altered filamin A enables Aβ signaling

brain. J Neurosci 2009;35:10961-73. and their contributions to protein stability and solubility. J Biol Chem
36. Wang H, Lee D, D’Andrea M, Peterson P, Shank R, Reitz A. beta- 2009;284:13285-9.
Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with 51. Lilja A, Porras O, Storelli E, Nordberg A, Marutle A. Functional
high affinity. Implications for Alzheimer’s disease pathology. J Biol interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic
Chem 2000;275:5626-32. receptors in Alzheimer’s disease. J Alzheimers Dis 2011;23:335-47.
37. Lauren J, Gimbel D, Nygaard H, Gilbert J, Strittmatter S. Cellular 52. Zhang L, Xie J, Yang J, Cao Y. Tyrosine phosphatase STEP61 negatively
prion protein mediates impairment of synaptic plasticity by amyloid- regulates amyloid b-mediated ERK/CREB signaling pathways via a7
beta oligomers. Nature 2009;457:1128-32. nicotinic acetylcholine receptors. J Neurosci Res 2013;91:1581-90.
38. Um J, Kaufman A, Kostylev M, Heiss J, Stagi M, Takahashi H, Kerrisk 53. Snyder E, Nong Y, Almeida C, Paul S, Moran T, Choi E, Nairn A,
M, Vortmeyer A, Wisniewski T, Koleske A, Gunther E, Nygaard H, Salter M, Lombroso P, Gouras G, Greengard P. Regulation of NMDA
Strittmatter S. Metabotropic glutamate receptor 5 is a coreceptor receptor trafficking by amyloid-beta. Nat Neurosci 2005;8:1051-8.
for Alzheimer Aβ oligomer bound to cellular prion protein. Neuron 54. Wang H, Stucky A, Liu J, Shen C, Trocme-Thibierge C, Morain P.
2013;79:887-902. Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor
39. Dinamarca M, Weinstein D, Monasterio O, Inestrosa N. The synaptic by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic
protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role acetylcholine and NMDA receptor function in Alzheimer’s disease
in Alzheimer’s disease? Biochemistry 2011;50:8127-37. brain. J Neurosci 2009;35:10961-73.
40. Zheng-Fischhöfer Q, Biernat J, Mandelkow E, Illenberger S, 55. Bloom G. Amyloid-β and tau: the trigger and bullet in Alzheimer
Godemann R, Mandelkow E. Sequential phosphorylation of Tau by disease pathogenesis. JAMA Neurol 2014;71:505-8.
glycogen synthase kinase-3beta and protein kinase A at Thr212 and 56. Lloret A, Fuchsberger T, Giraldo E, Viña J. Molecular mechanisms
Ser214 generates the Alzheimer-specific epitope of antibody AT100 and linking amyloid β toxicity and Tau hyperphosphorylation in
requires a paired-helical-filament-like conformation. Eur J Biochem Alzheimer׳s disease. Free Radic Biol Med 2015;83:186-91.
1998;252:542-52. 57. Talbot K, Wang H, Kazi H, Han L, Bakshi K, Stucky A, Fuino R,
41. Wang J, Xia Y, Grundke-Iqbal I, Iqbal K. Abnormal hyperphosphorylation Kawaguchi K, Samoyedny A, Wilson R, Arvanitakis Z, Schneider
of tau: sites, regulation, and molecular mechanism of neurofibrillary J, Wolf B, Bennett D, Trojanowski J, Arnold S. Demonstrated brain
degeneration. J Alzheimers Dis 2013;33:S123-39. insulin resistance in Alzheimer’s disease patients is associated with
42. Oueslati A. Implication of alpha-synuclein phosphorylation at S129 IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin
in synucleinopathies: what have we learned in the last decade? J Invest 2012;122:1316-38.
Parkinsons Dis 2016;6:39-51. 58. Bateman RJ, Xiong C, Benzinger T, Fagan A, Goate A, Fox N, Marcus
43. Stossel T, Condeelis J, Cooley L, Hartwig J, Noegel A, Schleicher M, D, Cairns NJ XX, Blazey TM, Holtzman DM, Santacruz A, Buckles
Shapiro S. Filamins as integrators of cell mechanics and signalling. V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade
Nature 2001;2:138-45. E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN,
44. Nakamura F, Stossel T, Hartwig J. The filamins: organizers of cell Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly
structure and function. Cell Adh Migr 2011;5:160-9. Inherited Alzheimer Network. Clinical and biomarker changes in
45. Vadlamudi R, Li F, Adam L, Nguyen D, Ohta Y, Stossel T, Kumar R. dominantly inherited Alzheimer’s disease. N Engl J Med 2012;367:795-
Filamin is essential in actin cytoskeletal assembly mediated by p21- 804.
activated kinase 1. Nat Cell Biol 2002;4:681-90. 59. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS,
46. Yue J, Huhn S, Shen Z. Complex roles of filamin-A mediated Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R,
cytoskeleton network in cancer progression. Cell Biosci 2013;3:7. Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW,
47. Penzes P, Vanleeuwen J. Impaired regulation of synaptic actin Lee VM, Shaw LM; Alzheimer’s Disease Neuroimaging Initiative.
cytoskeleton in Alzheimer’s disease. Brain Res Rev 2011;67:184-92. Update on the biomarker core of the Alzheimer’s disease neuroimaging
48. Stucky A, Bakshi K, Friedman E, Wang H. Prenatal cocaine exposure initiative subjects. Alzheimers Dement 2010;6:230-8.
upregulates BDNF-TrkB signaling. PLoS One 2016;11:e0160585. 60. Hefter D, Kaiser M, Weyer S, Papageorgiou I, Both M, Kann O, Müller
49. Ui N. Conformational studies on proteins by isoelectric focusing. Ann U, Draguhn A. Amyloid precursor protein protects neuronal network
N Y Acad Sci 1973;209:198-209. function after hypoxia via control of voltage-gated calcium channels. J
50. Pace C, Grimsley G, Scholtz J. Protein ionizable groups: pK values Neurosci 2016;36:8356-71.

Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ December 8, 2017 271